Azitra, Inc.
AMEX:AZTRBiotechnology
Healthcare
$1.53 +113.99%
+$0.82 today
- Market cap
- $92.72M
- Beta
- -1.04
- P/E (TTM)
- -1.2
- EPS (TTM)
- -$0.64
52W Low $0.05High $2.13
Volume 146.25M
Average 11.12M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$10.97M
FY 2025 · Annual
Net Income
-$10.96M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 110K | 284K | 686K | 7.5K | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 110K | 284K | 686K | 7.5K | 0 |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | — |
| Research & Development | 5.38M | 6.1M | 3.64M | 4.72M | 4.84M |
| Selling, General & Admin | 3.95M | 3.64M | 4.49M | 6.27M | 6.13M |
| Operating Expenses | 9.33M | 9.74M | 8.14M | 10.99M | 10.97M |
| Depreciation & Amortization | 84.77K | 405.98K | 425.55K | 448.24K | 453.14K |
| EBITDA | (8.79M) | (10.02M) | (10.67M) | (8.5M) | (10.49M) |
| EBITDA Margin | -7989.0% | -3529.0% | -1555.9% | -113307.5% | — |
| Operating Income | (9.22M) | (9.45M) | (7.45M) | (10.99M) | (10.97M) |
| Operating Margin | -8383.1% | -3328.7% | -1086.1% | -146468.5% | — |
| Interest Income | 8.76K | 4.82K | 1.58K | 122.55K | 70.21K |
| Interest Expense | 66.97K | 251.89K | 167.73K | 12.16K | 7.59K |
| Other Income / Expenses | 281.78K | (1.23M) | (3.82M) | 2.03M | 19.61K |
| Income Before Tax | (8.94M) | (10.68M) | (11.27M) | (8.96M) | (10.95M) |
| Pre-Tax Margin | -8127.0% | -3760.7% | -1642.3% | -119446.1% | — |
| Income Tax Expense | 0 | 0 | 17.31K | 9.03K | 8.32K |
| Net Income | (8.94M) | (10.68M) | (11.28M) | (8.97M) | (10.96M) |
| Net Margin | -8127.0% | -3760.7% | -1644.9% | -119566.6% | — |
| EPS (Basic) | (193.55) | (222.33) | (208.74) | (15.78) | (2.25) |
| EPS (Diluted) | (193.55) | (222.33) | (208.74) | (15.78) | (2.25) |
| 60.49K | 60.49K | 60.55K | 568.24K | 4.87M | |
| 60.49K | 60.49K | 60.55K | 568.24K | 4.87M |
AZTR Earnings Waterfall · TTM
AMEX:AZTR · Revenue to Net Income
Key Ratios
EPS$-1.30
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-0.3
P/S Ratio0.0
Analysis
$0 of revenue converted into -$12.3M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.30, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Oct 26, 2026 | |
| 8-K | Current report | Oct 22, 2026 | |
| 8-K | Current report | Oct 1, 2026 | |
| 8-K | Current report | Sep 28, 2026 | |
| 424B5 | 424B5 filing | Sep 28, 2026 |
How much revenue does AZTR generate?
Azitra, Inc. (AZTR) reported $0.00 of revenue in fiscal 2025.
Is AZTR profitable?
Azitra, Inc. (AZTR) reported -$10.96M of net income.
Continue the stock analysis
Jump to another research area for this company.